Jubilant Ingrevia Ltd - 543271 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jubilant Ingrevia management will participate in the Nuvama India Conference 2026 in Singapore on August 11 & 12, 2026. They will hold in-person one-on-one meetings with investors and analysts.
Aug 04 2026 17:33:41
Jubilant Ingrevia Ltd - 543271 - Communication Sent To The Shareholders Regarding Deduction Of Tax At Source (TDS) On Final Dividend For FY 2025-26
Jubilant Ingrevia declared a final dividend of Rs.2.50 per equity share for FY26. The record date is July 24, 2026. The company also issued detailed communication on Tax Deduction at Source (TDS) procedures for resident and non-resident shareholders.
Aug 01 2026 18:21:19
Jubilant Ingrevia Ltd - 543271 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Jubilant Ingrevia has uploaded the audio recording of its investor conference call, held on July 23, 2026, to discuss the un-audited financial results for the quarter ending June 30, 2026. The recording provides access to detailed discussions about the company's Q1 FY27 performance.
Jul 23 2026 21:31:04
Jubilant Ingrevia Ltd - 543271 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jubilant Ingrevia reported strong Q1 FY27 results, with revenue growing 25% YoY to Rs.1,300 crore and net profit increasing 41% YoY to Rs.106 crore. EBITDA grew 36% YoY to Rs.209 crore, with a 16% margin.
Jul 22 2026 14:40:24
Jubilant Ingrevia Ltd - 543271 - Board Meeting Outcome for Outcome Of The Board Meeting Held On July 22, 2026
Jubilant Ingrevia's board approved Q1 FY27 consolidated financial results. Consolidated revenue grew 25.28% YoY to ₹1300.27 crore and net profit rose 40.90% YoY to ₹105.82 crore. The results were reviewed by the Audit Committee and approved by the Board on July 22, 2026.
Jul 22 2026 12:36:29
Jubilant Ingrevia Ltd - 543271 - Board Meeting Intimation for Intimation Of Board Meeting - July 22, 2026
Jubilant Ingrevia's Board of Directors will hold a meeting on July 22, 2026. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the first quarter of fiscal year 2027.
Jul 13 2026 16:11:21
Read More